Search

You searched for "emergency"

645 results found

Which kidney to remove? – The urine separator

4 September 2025 | | URO - Technology
In this series of articles, I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk) this time helped by Hamza, one of our Leicester registrars who I recently...
Journal of Pediatric Urology cover image.

Ten years of experience with intravesical and intrasphincteric botulinum toxin A in children

1 July 2017 | | URO - Paediatrics
This is one of the longest follow-up studies of botulinum toxin A usage in children with bladder dysfunction in the paediatric literature. Fifty-three children had Botox® (Allergan) injected for a variety of reasons (spina bifida – 18, acquired cord injury...
Journal of Pediatric Urology cover image.

How successful is the transition to adult urology care in spina bifida?

1 May 2017 | | URO - Functional / Reconstructive Urology, URO - Paediatrics
These authors from Indianapolis, USA, aimed to assess rates and predictors of successful transition into adult care of spina bifida patients. They did this by a retrospective review of 77 patients discharged from a multidisciplinary paediatric clinic at a mean...
Urology journal cover image.

How often are instruments changed in RALP & RAPN?

1 January 2016 | | URO - Endourology & Stones, URO - Urologic Oncology
This study investigates how often the robotic instruments are exchanged during robotic-assisted laparoscopic prostatectomy (RALP) and robot-assisted partial nephrectomy (RAPN). They presently come with a life span of 10 uses but whether all instruments are used fully on 10 different...
Journal of Pediatric Urology cover image.

Bladder urothelial neoplasms in children

1 January 2016 | | URO - Paediatrics
Urothelial bladder neoplasms are rare in children, occurring in 0.1-0.4% of the population before the age of 20. There are no current paediatric guidelines to their management. This study retrospectively reviews the files of patients from three tertiary centres between...

Join Prostate Cancer Research Free Webinar for Healthcare Professionals

11 December 2025
Managing Sexual Side Effects After Prostate Cancer: A Patient & Therapist Perspective Date: 20 January 2026 — 6.00pm (London)Register: https://zoom.us/webinar/register/WN_CstOkvaUSNSg_xlFI1Z27w Why attend?Sexual side effects remain one of the most challenging and under-discussed consequences of prostate cancer treatment. This focused webinar...

Bladder Health UK (BHUK) Trustee recruitment: strengthening governance and strategic leadership

10 August 2026 | Recruitment & Personnel
Bladder Health UK (BHUK) is seeking new Trustees to enhance our governance, strengthen oversight and support the charity’s continued growth as a national leader in bladder health. For over 30 years, BHUK has delivered trusted patient information, a national helpline,...

Recent developments in bladder cancer

1 September 2018 | | URO - Urologic Oncology
There have been some exciting developments in bladder cancer over the last few years. Immunotherapy has prolonged survival in a proportion of patients with metastatic disease, with sustained efficacy in some. Advances in genetic analysis and molecular subtyping make personalised...

Immunotherapy in renal cancer

1 May 2019 | | URO - Basic Science Research, URO - Urologic Oncology
Renal cell carcinoma (RCC) is the sixth most common solid organ cancer in the UK. In 2018, there were 403,262 people diagnosed worldwide with the disease (2.2% of all cancer cases), and it accounted for 175,098 deaths in total (1.8%...

Thermal ablative techniques for small renal masses

1 July 2017 | | URO - Urologic Oncology, URO - Technology
The incidence of renal cell carcinoma has increased over the past decade which can be partly attributed to the increased use of imaging modalities [1,2]. Nephron sparing procedures for the management of small renal tumours have gained popularity which include...

Demanding cases or nightmares in uro-oncology? Jan/Feb 2022

5 January 2022 | | URO - Urologic Oncology
When less is more: percutaneous biopsy and tumour seeding in papillary renal cell carcinoma Renal cell carcinoma (RCC) accounted for 2.2% of new cancer diagnoses worldwide in 2018 with over 400,000 new cases and 175,098 deaths [1]. The majority of...

Recent advances in the management of castration resistant prostate cancer

1 November 2017 | | URO - Urologic Oncology
Castrate resistant prostate cancer (CRPC) is defined by disease progression despite androgen-deprivation therapy lowering testosterone to castrate levels. It may present as a rise in serum levels of prostate specific antigen (PSA), progression of pre-existing disease, or the appearance of...